NEUROTRANSMITTER AGENTS
Clinical trials for NEUROTRANSMITTER AGENTS explained in plain language.
Never miss a new study
Get alerted when new NEUROTRANSMITTER AGENTS trials appear
Sign up with your email to follow new studies for NEUROTRANSMITTER AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to smooth neck bands in major trial
Symptom relief Recruiting nowThis study tests an injection called NT 201 (a type of botulinum toxin) to see if it safely reduces the appearance of prominent neck bands (platysma prominence) in adults. About 300 people with moderate to severe neck bands will receive either NT 201 or a placebo. The goal is to …
Matched conditions: NEUROTRANSMITTER AGENTS
Phase: PHASE3 • Sponsor: Merz North America, Inc. • Aim: Symptom relief
Last updated May 17, 2026 08:00 UTC
-
New drug HNK shows promise for Treatment-Resistant depression in early trial
Symptom relief Recruiting nowThis study tests a new drug called (2R,6R)-HNK to see if it can quickly improve symptoms in people with major depression that hasn't responded to other treatments. About 50 adults aged 18 to 70 will receive four infusions of HNK and four of a placebo over several weeks, with thei…
Matched conditions: NEUROTRANSMITTER AGENTS
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated May 15, 2026 12:07 UTC
-
Could a ketamine mist lift severe depression fast? new trial aims to find out.
Symptom relief Recruiting nowThis study tests whether inhaling ketamine through a nebulizer can reduce symptoms of moderate to severe depression in hospitalized adults. Forty participants will receive either ketamine or an active placebo (midazolam) and be monitored for changes in depression scores over abou…
Matched conditions: NEUROTRANSMITTER AGENTS
Phase: PHASE3 • Sponsor: Theresa Jacob, PhD, MPH • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
New injection may smooth neck bands in major trial
Symptom relief Recruiting nowThis study tests an injection called NT 201 (a type of botulinum toxin) against a placebo in 300 adults with moderate to severe neck band prominence. The goal is to see if it safely reduces the appearance of these bands. Participants will be followed for several weeks, and those …
Matched conditions: NEUROTRANSMITTER AGENTS
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated May 11, 2026 20:51 UTC
-
NIH launches study to unlock secrets of mood disorder treatments
Knowledge-focused Recruiting nowThis study aims to learn more about how depression, bipolar disorder, and suicide risk affect people and how treatments work. Researchers will follow 500 adults already receiving care at the NIH, using interviews, questionnaires, and optional tests like blood draws and brain scan…
Matched conditions: NEUROTRANSMITTER AGENTS
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC